Consuela A. Albright: Building a More Connected Sickle Cell Care System
Consuela A. Albright, Nurse Practitioner at Cleveland Clinic, shared a post on LinkedIn:
”Today’s spotlight is personal — this is my team.
Sometimes the most effective advocacy is redesigning the system itself — and Cleveland Clinic’s Sickle Cell Disease Medical Neighborhood is a local example of exactly that, one I’m proud to be part of.
The program was built around a simple but overdue idea: sickle cell warriors have historically navigated fragmented, reactive care — bouncing between the ER, inpatient stays, and outpatient visits with little coordination between them.
The Medical Neighborhood model replaces that with a dedicated team that follows patients throughout their lives, bridging emergency care, hospitalizations, outpatient visits, and specialty services into one coordinated experience.
I want to name the people who make that coordination real.
Medical Directors Ravi Talati and Crawford Strunk, who lead the clinical vision for this program.
RN Coordinator Katrina Seedhouse, who holds the day-to-day threads of patient care together.
Social Workers Rosa Young and Milvon Bryson who address the parts of this disease that a clinical visit alone never touches.
And CCF Pediatric Hematology Department Chair Rabi Hanna, whose leadership shapes how this care gets built from the ground up.
I’ve worked in outpatient oncology settings with sickle cell patients, and I’ve seen firsthand what happens when coordination doesn’t exist — the same history repeated to five different providers, gaps in follow-up, patients who stop trusting a system that keeps failing to talk to itself.
This team is advocacy translated into clinical infrastructure, right here in our own city, and I’m grateful to work alongside them.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis